SIRPα-Fc administration resulted in increased amounts of tumor-infiltrating macrophages (Figure 2G,H), enhanced TNF-α production (Figure 2I), and a reduction in IL-10 expression (Figure 2J). Here, SIRPA is linked to neoplasm.